# Pulmonary Arterial Hypertension trials recruiting: 30 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 30 trials with no drug phase for Pulmonary Arterial Hypertension that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Pulmonary Arterial Hypertension trials with no drug phase: 30 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 4 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/not-applicable/pulmonary-arterial-hypertension

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 30
- Recruiting or not yet: 30
- Read on: November 19, 2026

## Trials

The 25 newest of 30, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 4, 2026 | NCT07917416 | Home-based Inspiratory Muscle Training in Pulmonary Hypertension | Universidad Complutense de Madrid | Not applicable | Not yet recruiting | Pulmonary Arterial Hypertension, Chronic Thromboembolic Pulmonary Hypertension | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07917416) |
| September 4, 2026 | NCT07804693 | Assessment of Total Pulmonary Resistance sPAP/CO Between Sea Level LA vs. High Altitude HA After Re-ascent in Patients With Pulmonary... | Sponsor not shown (see the record) | Not applicable | Not yet recruiting | Pulmonary Arterial Hypertension (PAH), Pulmonary Vascular Disease, High Altitude, Echocardiography, Pulmonary Resistance | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07804693) |
| September 4, 2026 | NCT07804576 | Assessment of Lung Function (Lufu) at Sea Level LA vs. High Altitude HA in Patients With Pulmonary Arterial Hypertension PAH | Sponsor not shown (see the record) | Not applicable | Not yet recruiting | Pulmonary Arterial Hypertension (PAH), Pulmonary Vascular Disease, High Altitude Effects, High Altitude, Lung Function... | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07804576) |
| September 4, 2026 | NCT07804524 | Assessment of Total Pulmonary Resistance sPAP/CO Between High Altitude HA vs. Sea Level LA in Patients With Pulmonary Arterial Hypertension... | Sponsor not shown (see the record) | Not applicable | Not yet recruiting | Pulmonary Arterial Hypertension (PAH), Pulmonary Vascular Disease, High Altitude, Echocardiography, Pulmonary... | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07804524) |
| September 4, 2026 | NCT07804472 | Assessment of Six-minute Walking Distance 6MWD Between High Altitude HA vs. Sea Level LA in Patients With Pulmonary Arterial Hypertension... | Sponsor not shown (see the record) | Not applicable | Not yet recruiting | Pulmonary Arterial Hypertension (PAH), Pulmonary Vascular Disease, Six-minute Walk Test, High Altitude Effects, High... | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07804472) |
| September 3, 2026 | NCT07801963 | Sleep-Assessment in Patients Between High Altitude HA vs. Sea Level LA in Patients With Pulmonary Arterial Hypertension PAH | Sponsor not shown (see the record) | Not applicable | Not yet recruiting | Pulmonary Arterial Hypertension (PAH), Pulmonary Vascular Disease, Polygraphy, Sleep, Sleep Disordered Breathing (SDB)... | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07801963) |
| September 3, 2026 | NCT07801859 | Assessment of Heart Rate Variability HRV During Descent DE From 2850m to Sea Level and During Re-ascent A From Sea Level to 2850m in... | Sponsor not shown (see the record) | Not applicable | Not yet recruiting | High Altitude Effects, High Altitude, Pulmonary Vascular Disease, Pulmonary Arterial Hypertension (PAH), Heart Rate... | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07801859) |
| September 2, 2026 | NCT07799675 | Telerehabilitation in Pulmonary Arterial Hypertension | Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud | Not applicable | Not yet recruiting | Pulmonary Arterial Hypertension (PAH) | 34 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07799675) |
| September 1, 2026 | NCT07797166 | Assessment of Six-minute Walking Distance Between Sea Level LA vs. High Altitude HA After Re-ascent in Patients With Pulmonary Arterial... | Sponsor not shown (see the record) | Not applicable | Not yet recruiting | Pulmonary Arterial Hypertension (PAH), Pulmonary Vascular Disease, Six-minute Walk Test, NYHA, High Altitude Effects... | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07797166) |
| August 24, 2026 | NCT07781709 | Understanding the Effects of Pulmonary Arterial Hypertension on Lean Muscle Mass-Substudy | University of Pennsylvania | Not applicable | Recruiting | Pulmonary Arterial Hypertension | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07781709) |
| August 20, 2026 | NCT07777445 | Exercise Performance on Ambient Air vs. Low-Flow Liquid Oxygen Therapy in Pulmonary Vascular Disease (PVD) | Sponsor not shown (see the record) | Not applicable | Recruiting | Pulmonary Vascular Disease, Chronic Thromboembolic Pulmonary Hypertension (CTEPH), Pulmonary Arterial Hypertension (PAH) | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07777445) |
| August 20, 2026 | NCT07777367 | Exercise Performance on Ambient Air vs. Low-Flow Liquid Oxygen Therapy in Chronic Lung Diseases | Sponsor not shown (see the record) | Not applicable | Recruiting | Pulmonary Vascular Disease, Chronic Thromboembolic Pulmonary Hypertension (CTEPH), Pulmonary Arterial Hypertension (PAH) | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07777367) |
| July 21, 2026 | NCT07717060 | Extracellular Vesicle Dynamics Predicting Vascular Complications and Treatment Response in Systemic Sclerosis | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Not applicable | Not yet recruiting | Systemic Sclerosis, Pulmonary Arterial Hypertension, Digital Ulcers, Vascular Complications | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07717060) |
| July 14, 2026 | NCT07700303 | Withdrawal of Prostacyclin Pathway Therapy in Patients With Pulmonary Arterial Hypertension Receiving Sotatercept (WATERLOO) | University of Alberta | Not applicable | Not yet recruiting | Pulmonary Arterial Hypertension | 78 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07700303) |
| July 13, 2026 | NCT07697235 | Impact of an Optimized Omega-3 Formulation on Inflammation and Endothelial Dysfunction in Pulmonary Arterial Hypertension | University Hospital, Strasbourg, France | Not applicable | Not yet recruiting | PAH | 22 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07697235) |
| June 25, 2026 | NCT07667829 | Vasopressor Agents in Pulmonary Hypertension Crisis | China National Center for Cardiovascular Diseases | Not applicable | Recruiting | Pulmonary Arterial Hypertension (PAH), Chronic Thromboembolic Pulmonary Hypertension (CTEPH), Hypertension, Pulmonary | 75 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07667829) |
| June 24, 2026 | NCT07666841 | Tele-Pulmonary Rehabilitation For Patients With Chronic Lung Diseases | Tel-Aviv Sourasky Medical Center | Not applicable | Recruiting | COPD (Chronic Obstructive Pulmonary Disease), Rehabilitation, Bronchiectasis Adult, Pulmonary Arterial Hypertension... | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07666841) |
| March 11, 2026 | NCT07464184 | Evolution of Hypoxic Burden and Sympathetic/Parasympathetic Balance in Patients With Pulmonary Hypertension | University Hospital, Rouen | Not applicable | Not yet recruiting | Precapillary Pulmonary Hypertension, Pulmonary Arterial Hypertension, Sleep-disordered Breathing, Nocturnal Hypoxemia... | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07464184) |
| March 9, 2026 | NCT07457762 | AIRDROP: Can we Improve Adherence to Inhaled Treatment for Pulmonary Arterial Hypertension? | University of Sao Paulo General Hospital | Not applicable | Recruiting | Pulmonary Arterial Hypertension (PAH) | 72 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07457762) |
| January 26, 2026 | NCT07366879 | Exercise Intervention as an Adjunct to Medical Therapy in Newly Diagnosed Patients With Pulmonary Arterial Hypertension | Golden Jubilee National Hospital | Not applicable | Recruiting | Pulmonary Arterial Hypertension | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07366879) |
| August 13, 2025 | NCT07120789 | Validation of a Patient Knowledge Questionnaire for Pulmonary Hypertension | University of Sao Paulo General Hospital | Not applicable | Recruiting | Pulmonary Arterial Hypertension (PAH), Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH), Pulmonary Hypertension | 215 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07120789) |
| May 23, 2025 | NCT06987097 | Ambrisentan for Early Low-Risk Pulmonary Arterial Hypertension | Nanjing First Hospital, Nanjing Medical University | Not applicable | Not yet recruiting | Pulmonary Arterial Hypertension (PAH) | 410 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06987097) |
| May 13, 2025 | NCT06968962 | Comparison of Sequential to Initial Combination Therapy in PAH | Second Affiliated Hospital, Zhejiang University, School of Medicine | Not applicable | Recruiting | Pulmonary Arterial Hypertension (PAH) | 376 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06968962) |
| February 27, 2025 | NCT06850792 | imprOving Adherence to Pulmonary artErial hyperteNsion Treatment With teLemedicIne and patieNt guidaNce | University of Sao Paulo General Hospital | Not applicable | Recruiting | Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH), Pulmonary Arterial Hypertension (PAH), Pulmonary Arterial... | 61 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06850792) |
| January 31, 2025 | NCT06804122 | Exercise-based Rehabilitation in Patients With Pulmonary Arterial Hypertension | Tampere Heart Hospital | Not applicable | Recruiting | Pulmonary Arterial Hypertension | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06804122) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| University of Sao Paulo General Hospital | 3 |
| Vanderbilt University Medical Center | 2 |
| Universidad Complutense de Madrid | 1 |
| University of Alberta | 1 |
| Tel-Aviv Sourasky Medical Center | 1 |
| Aria CV, Inc | 1 |
| University Hospital, Strasbourg, France | 1 |
| University of Pennsylvania | 1 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 1 |
| Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud | 1 |
| Shanghai Zhongshan Hospital | 1 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 1 |
| China National Center for Cardiovascular Diseases | 1 |
| University Hospital, Rouen | 1 |
| Nanjing First Hospital, Nanjing Medical University | 1 |
| Universitaire Ziekenhuizen KU Leuven | 1 |
| Tampere Heart Hospital | 1 |
| Golden Jubilee National Hospital | 1 |

## By country

| Country | Trials |
| --- | --- |
| Switzerland | 9 |
| United States | 4 |
| China | 3 |
| Brazil | 3 |
| Spain | 2 |
| Canada | 1 |
| Israel | 1 |
| France | 1 |
| Belgium | 1 |
| Finland | 1 |
| United Kingdom | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Plastics companies in the United States](https://specstream.ai/data/businesses/plastics-companies/united-states)
- [Aircraft manufacturers in the United States](https://specstream.ai/data/businesses/aircraft-manufacturers/united-states)
- [Electric utilities in the United States](https://specstream.ai/data/businesses/electric-utilities/united-states)
- [Metal suppliers in the United States](https://specstream.ai/data/businesses/metal-suppliers/united-states)
- [Tools wholesalers in the United States](https://specstream.ai/data/businesses/tools-wholesalers/united-states)
- [Cigar bars in the United States](https://specstream.ai/data/businesses/cigar-bars/united-states)
